A Study to Investigate the Effect of Elecoglipron on Rosuvastatin and Atorvastatin in Healthy Participants
Clinical trial NCT07534592 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT07534592
- Sponsor
- AstraZeneca
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-04-16
- Primary completion
- 2026-08-28
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.